Pharmacokinetic Variables Completed Phase 1 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0041208 (Pharmacokinetic Variables)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00719693Assessment of the Effect of Food on ABT-143 BioavailabilityBasic Science
NCT00728780Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.Treatment